Headache & Migraine explores the potential role of medical cannabis and cannabis-based products for medicinal use (CBPMs) in managing migraine, cluster headaches, and other headache disorders in the UK in 2025. Articles in this category cover current evidence, private clinic access, preventive vs acute use, CBD vs THC considerations, risks, legal notes, and important disclaimers. All content is educational only — not medical advice. Always consult a specialist doctor.
Endometriosis affects around 1 in 10 women and people with uteruses in the UK, causing severe pelvic pain, painful periods, […]
Migraine and cluster headaches affect millions in the UK, with migraine alone impacting ~1 in 7 adults. Standard treatments (triptans,